Headline
The latest stories from AHA Today.
The San Francisco Department of Public Health Jan. 10 announced a presumptive positive case of H5N1 bird flu in a child after they experienced symptoms of fever and conjunctivitis.
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers in health care settings.
The U.S. Chamber of Commerce Jan. 13 filed a lawsuit against the Federal Trade Commission, saying changes made by the FTC to premerger notification rules under the Hart-Scott-Rodino Act are “unnecessary and unlawful.”
The Centers for Medicare & Medicaid Services Jan. 10 proposed a 4.3% payment increase to Medicare Advantage plans for calendar year 2026, amounting to approximately $21 billion.
The AHA Jan. 13 launched a new television and multimedia advertising campaign highlighting how hospitals and health systems are there for all of life’s moments, 24/7/365, caring for patients and communities across the country.
The AHA urged the Medicare Payment Advisory Commission to update payment recommendations for hospitals, post-acute care facilities and physicians in advance of the commission's Jan. 16 public meeting. AHA urged MedPAC to issue a higher update than the current-law market basket update plus an…
The Department of Health and Human Services has released its Strategic Plan for the Use of Artificial Intelligence in Health, Human Services, and Public Health, a guide that seeks to clarify regulatory oversight, coverage and payment determinator processes for AI as well as refine existing…
Total medical school enrollment has reached a new high of 99,562 students for 2024-2025, a 1.8% increase from the previous school year, according to data released Jan. 10 by the Association of American Medical Colleges.
Highlights from the AHA's Advancing Health podcast include selections on obstetric services in rural communities and the growing role of chief wellness officers.
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by the AARP Public Policy Institute.